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S1
The scheme was introduced in stages. Phase 1, introduced in February 2008, applied to diesel-powered heavy goods vehicles (HGVs) weighing greater than 12 tonnes.
Phase 2 followed in July 2008 applying to HGVs over 3.5 tonnes. Phases 3 and 4 were introduced simultaneously in January 2012, restricting access to heavier Light Goods
Vehicles and mini-buses not meeting the Euro III standard, and increasing the restriction on buses, coaches and HGVs greater than 3.5 tonnes from emission standard Euro III to Euro IV. In this paper for simplicity we refer to three phases of introduction, with phase three, encompassing the LEZ phases 3 and 4. For a fuller description of the LEZ we refer the reader to the review of Hollman et al (2015) .
S2
Over a 10-year horizon the predicted impact of the Low Emission Zone within
Greater London was to regain 5,000 years of life that would otherwise have been lost, reduce by a quarter of a million the number of restricted activity days, reduce the severity of 300,000 acute respiratory episodes, and deliver health benefits to the value of up to £450m. scaling factors measurements from 9-13 and 14-20 background and roadside sites were averaged, respectively. All measurements were taken from the London Air Quality
Monitoring Network (LAQN, www.londonair.org.uk).
Nowcast method evaluation
The Nowcast method has previously been evaluated according to the metrics recommended for the evaluation of air quality models by the Department for Environment, Table s3 . There was a bias evident in both pollutant models, with the Nowcast tending to under predict measured concentrations. This is due to two factors: (1) the 20 m resolution of the model means that it cannot reflect high concentrations within a few metres of roads and may underestimate kerbside concentrations and (2) part of the Nowcast calculation is based on median rather than mean concentrations to avoid undue influence from extraneous high or low measurements. The normalised mean bias for NO2 and PM10 is within the DEFRA recommended bounds of ± 20% and the FAC2 (fraction of predictions within a factor of 0.5 to 2) is well above the recommended 50%. Table s4 shows Nowcast performance at each of the 16 PM10 monitoring sites in the evaluation. The FAC2 is greater than 50% at all sites meeting the DEFRA criteria. The normalised mean bias is inside the DEFRA recommended range of ± 20% at 13 sites. At three sites close to roads (highlighted in grey) normalised mean bias is outside the range of ± 20%. At these sites the 20 m model resolution cannot fully represent peak concentrations within a few metres of traffic sources. Quality control was based on the ATS/ERS guidelines S11 , modified for children S12 . Additional acceptability requirements were: rapid onset of expiration, high well-defined peak flow and a clear plateau on volume-time curve together with no evidence of cough, glottis closure or leak during the manoeuvre (from Asthma UK/ Growing Lungs Guidelines). For quality control and reporting purposes spirometry results were uploaded from the 3 study spirometers to a Carefusion program "Spirometry" where individual inspection of efforts was undertaken in detail.
Reporting of results was according to ATS-ERS Guidelines and the best overall
individual effort from each child both pre and post salbutamol was selected as the highest value of FEV1 and FVC, together with FEF25-75 from the best combined effort, reported from technically acceptable data, which met reproducibility requirements of 0.15 L agreement for FEV1 and FVC for 2 efforts. Data were then extracted into Excel and individual efforts were cross checked with original data before being exported into the main study Access database. Raw data were transformed into Z (or standard deviation) scores using most the "All-Age" equations by Stanojevic et al.,
available for white subjects aged 3 to 80 years of age. S13 Severe wheeze ≥1night/week of sleep disturbed by wheezing in the past 12 months; wheezing severe enough to limit speech to only one or two words at a time between breaths in the past 12 months.
Rhinitis
In the past 12 months, has your child had a problem with sneezing, or a runny, or a blocked nose when he/she DID NOT have a cold or the flu?
Eczema
Has your child ever had an itchy rash which was coming and going for at least 6 months? AND Has your child had this itchy rash at any time in the last 12 months? AND Has this itchy rash at any time affected any of the following places: the folds of the elbows, behind the knees, in front of the ankles, under the buttocks, or around the neck, ears or eyes? Lifetime Asthma Has your child ever had asthma? Hay fever Has your child ever had hay fever? Eczema Has your child ever had eczema? Table s11 : Lung function post-bronchodilator by study year aggregated across sites. Panels E and F illustrate the equivalent data for PM2.5. *** 8 significance at the <0.001, ** significance at <0.01, * significance at <0.05, per site and 9 aggregated across sites. 10 For exposure attributions at residential address (home): NOx, 12.2; NO2, 4.8; PM10, 2.1; PM2.5, 1.7 g/m 3 . For exposure attributions weighted for periods spent at home and school: NOx, 11.5; NO2, 4.6; PM10, 2.0; PM2.5, 1.6 g/m 3 . 
